Stock listing
NASDAQ:OREX Orexigen Therapeutics Inc Stock
Follow Orexigen Therapeutics Inc into a list and get an email when it puts out news.
Delisted NASDAQ:OREX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:OREX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Orexigen Therapeutics Inc on 6ix
- Decks
- 24 decks · latest Jan 19, 2018
Where Orexigen Therapeutics Inc is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:OREX · This page · Delisted | NASDAQ | United States | USD |
| OTC:OREXQ · Delisted | OTC | United States | USD |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Corporate Update (January 2018) | Corporate update | 17 slides | Jan 19, 2018 |
| Corporate Update (January 2018) | Corporate update | 21 slides | Jan 8, 2018 |
| BIO Investor Forum 2017 | Conference | 32 slides | Oct 16, 2017 |
| Cantor Fitzgerald Healthcare Conference 2017 | Conference | 36 slides | Sep 26, 2017 |
| Corporate Update (March 2017) | Corporate update | 56 slides | Mar 8, 2017 |
| Investor Conferences February 13-17, 2017 | Conference | 55 slides | Feb 9, 2017 |
| J.P. Morgan 35th Annual Healthcare Conference (January 2017) | Conference | 42 slides | Jan 12, 2017 |
| J.P. Morgan 35th Annual Healthcare Conference (January 2017) | Conference | 40 slides | Jan 9, 2017 |
| Merger or Acquisition (March 2016) | Merger or acquisition | 43 slides | Mar 15, 2016 |
| J.P. Morgan 34th Annual Healthcare Conference 2016 | Conference | 28 slides | Jan 11, 2016 |
All 24 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2015 Earnings Presentation | Earnings | 30 slides | Nov 5, 2015 |
| JP Morgan Healthcare Conference 2015 | Conference | 22 slides | Jan 12, 2015 |
| Investor Presentation (January 2014) | Investor deck | 43 slides | Jan 13, 2014 |
| Investor Presentation (September 2012) | Investor deck | 32 slides | Sep 20, 2012 |
| Investor Presentation (September 2012) | Investor deck | 31 slides | Sep 5, 2012 |
| 2012 JPMorgan Annual Healthcare Conference | Conference | 31 slides | Jan 10, 2012 |
| JMP Securities Healthcare Conference 2011 | Conference | 25 slides | Sep 27, 2011 |
| Investor Presentation (December 2010) | Investor deck | 25 slides | Dec 17, 2010 |
| Investor Presentation (April 2010) | Investor deck | 66 slides | Apr 13, 2010 |
| 28th Annual JP Morgan Healthcare Conference (January 2010) | Conference | 30 slides | Jan 11, 2010 |
| Technical Presentation (September 2009) | Technical | 16 slides | Sep 30, 2009 |
| Technical Presentation (July 2009) | Technical | 22 slides | Jul 20, 2009 |
| Investor Presentation (June 2009) | Investor deck | 37 slides | Jun 2, 2009 |
| Technical Presentation (January 2009) | Technical | 14 slides | Jan 9, 2009 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Wendy L Dixon Other companies: Zevra Therapeutics, Inc. (Director · Since at least Apr 25, 2023); Iovance Biotherapeutics, Inc. (Director · Jun 10, 2022 – Jun 10, 2022 · Past); Black Diamond Therapeutics, Inc. (Director · Apr 6, 2022 – Mar 15, 2024 · Past); Arvinas, Inc. (Director · Jun 29, 2020 – Jun 15, 2023 · Past); Sesen Bio Inc (Director · Jun 12, 2018 – Jun 19, 2019 · Past); Voyager Therapeutics, Inc. (Director · Jan 1, 2017 – Jun 4, 2020 · Past); Eleven Biotherapeutics Inc (Director · Oct 22, 2014 – May 19, 2017 · Past); Bluebird bio Inc (Director · Jun 18, 2013 – Nov 11, 2021 · Past); Ardea Biosciences Inc (Director · Apr 6, 2011 – Jun 19, 2012 · Past); Alkermes plc (Director · Jan 13, 2011 – Jun 14, 2022 · Past); Furiex Pharmaceuticals Inc (Director · May 27, 2010 – Jul 2, 2014 · Past); Incyte Corporation (Director · May 21, 2010 – Mar 31, 2022 · Past); Dentsply Sirona Inc. (Director · Jul 31, 2007 – Jul 8, 2010 · Past); Bristol-Myers Squibb Company (CMO & Pres, Global Marketing · Mar 7, 2006 – May 22, 2006 · Past) | Director · Apr 20, 2010 – Jun 9, 2015 · Past |
| Lota S Zoth Other companies: First Financial Bankshares, Inc. (Director · Since at least Apr 28, 2026); enGene Therapeutics Inc. (Director · Since at least Dec 18, 2023); 89bio Inc (Director · Since at least Jun 1, 2020); Inovio Pharmaceuticals, Inc. (Director · Since at least Jan 3, 2019); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Spark Therapeutics Inc (CHIEF SCIENTIFIC OFFICER, Director · Jan 6, 2016 – Dec 17, 2019 · Past); Lumos Pharma Inc (Director · Nov 2, 2012 – Dec 12, 2024 · Past); Hyperion Therapeutics Inc (Director · Jul 25, 2012 – May 7, 2015 · Past); Medimmune Inc (SVP, Chief Financial Officer · Feb 23, 2006 – Jun 18, 2007 · Past) | Director · Apr 26, 2012 – Jul 14, 2017 · Past |
| Preston Klassen Other companies: Regulus Therapeutics Inc (President & Head of R & D, Director · Since at least Jun 12, 2023); Zura Bio Limited (President and COO · Mar 20, 2023 – Mar 20, 2023 · Past); Metacrine Inc (Director · Sep 15, 2020 – Mar 23, 2023 · Past); Arena Pharmaceuticals Inc (EVP and CMO · Mar 20, 2017 – Mar 1, 2020 · Past); Histogen Inc (Director · Feb 7, 2014 – Jun 27, 2019 · Past) | EVP, Global Development · May 27, 2010 – Feb 2, 2016 · Past |
| David J. Endicott Other companies: Alcon AG (Chief Executive Officer · Since at least Aug 10, 2026); MiniMed Group, Inc. (Director · Since at least Jun 29, 2026); Zeltiq Aesthetics Inc (Director · Apr 25, 2016 – Apr 28, 2017 · Past); Hospira Inc (Pres., Hospira Medical Devices · Mar 10, 2014 – Sep 3, 2015 · Past) | Director · Nov 29, 2012 – Jul 14, 2017 · Past |
| Debora Jorn Other companies: EyePoint, Inc. (EVP, Corp. & Comm'l Dev. · Nov 2, 2016 – Jun 27, 2017 · Past); Viveve Medical, Inc. (Director · Aug 22, 2016 – Jan 3, 2023 · Past); Bausch Health Companies Inc. (EVP, Company Group Chairman · May 20, 2015 – Nov 20, 2015 · Past) | Director · May 20, 2016 – Jul 14, 2017 · Past |
| Dennis Kim Other companies: Skye Bioscience, Inc. (Chief Medical Officer · Aug 21, 2019 – Aug 7, 2020 · Past); Sesen Bio Inc (Chief Medical Officer · Dec 3, 2018 – Dec 3, 2018 · Past); Larimar Therapeutics, Inc. (Chief Medical Officer · Jun 18, 2014 – Jan 22, 2019 · Past) | Sr. VP, Corporate Development · Feb 27, 2009 – Apr 23, 2009 · Past |
| Michael Narachi Other companies: Ultragenyx Pharmaceutical Inc. (Director · Since at least Feb 20, 2015); Eiger Biopharmaceuticals Inc (Director · Jan 29, 2014 – Jun 4, 2015 · Past); AMAG Pharmaceuticals Inc (Director · Nov 27, 2007 – May 23, 2013 · Past) | CEO & President, Director · Mar 31, 2009 – Oct 13, 2017 · Past |
| Peter Honig Other companies: Karyopharm Therapeutics Inc. (Director · Dec 3, 2021 – May 24, 2023 · Past); Sesen Bio Inc (Director · Jul 20, 2021 – Jun 22, 2022 · Past); Eiger Biopharmaceuticals Inc (Director · Mar 2, 2014 – Jun 4, 2015 · Past) | Director · Jun 5, 2013 – Jul 14, 2017 · Past |
| Louis C Bock Other companies: Horizon Pharma PLC (Director · Jul 28, 2011 – Aug 2, 2011 · Past); Zogenix Inc (Director · Nov 22, 2010 – Mar 7, 2022 · Past) | Director · May 27, 2010 – Jul 14, 2017 · Past |
| Thomas P Lynch Other companies: BillionToOne, Inc. (See Remarks · Since at least Nov 5, 2025); Nuwellis, Inc. (Chief Legal Compliance Officer · May 20, 2020 – Jan 22, 2021 · Past) | EVP, Chief Admin Off, GC & Sec · Jul 12, 2016 – Oct 13, 2017 · Past |
All 14 people
| Person | Seat |
|---|---|
| Peter D Flynn Other companies: Fate Therapeutics, Inc. (See remarks · Sep 30, 2013 – Jan 5, 2015 · Past) | EVP, Head of Global Dev · Jun 8, 2016 – Oct 13, 2017 · Past |
| Carol A Baum | VP, Commercialization · Feb 27, 2009 – Apr 23, 2009 · Past |
| Mark D Booth | Chief Commercial Officer · Sep 1, 2010 – Feb 26, 2015 · Past |
| Stephen A Moglia | VP & Chief Accounting Officer · Dec 11, 2015 – Mar 15, 2018 · Past |
Log in to ask 6ix AI your own questions about Orexigen Therapeutics Inc.